Ticker Details
Cerus Corporation Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety.
IPO Date:	January 31, 1997
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$631.16M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.13 | 3.13%
Avg Daily Range (30 D):	$0.09 | 3.37%
Avg Daily Range (90 D):	$0.09 | 3.76%

Institutional Daily Volume
Avg Daily Volume:	.78M
Avg Daily Volume (30 D):	2.34M
Avg Daily Volume (90 D):	2.18M

Trade Size
Avg Trade Size (Sh.):	180
Avg Trade Size (Sh.) (30 D):	185
Avg Trade Size (Sh.) (90 D):	192

Institutional Trades
Total Institutional Trades:	1,006
Avg Institutional Trade:	$1.27M
Avg Institutional Trade (30 D):	$1.32M
Avg Institutional Trade (90 D):	$1.22M
Avg Institutional Trade Volume:	.26M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.25M
Avg Closing Trade (30 D):	$1.36M
Avg Closing Trade (90 D):	$1.19M
Avg Closing Volume:	239.16K

News

Jul 17, 2024 @ 12:21 PM ASML Reports Q2 Results, Joins Spirit Airlines And... Source: Avi Kapoor

Jul 17, 2024 @ 10:03 AM Why Bloom Energy Group Shares Are Trading Higher B... Source: Avi Kapoor

Apr 8, 2024 @ 12:24 PM Perion Network Cuts Sales Outlook, Joins Range Res... Source: Avi Kapoor

Mar 21, 2024 @ 3:40 AM Cathie Wood's Ark Invest Sells Another Tranche Of ... Source: Benzinga Neuro

Mar 14, 2024 @ 3:41 AM Cathie Wood's Ark Invest Sells Coinbase Shares As ... Source: Benzinga Neuro

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.08	$-.01	$-.08
Diluted EPS	$-.08	$-.01	$-.08
Revenue	$233.8M	$130.42M	$233.8M
Gross Profit
Net Income / Loss	$-15.64M	$-2.18M	$-15.64M
Operating Income / Loss	$-8.68M	$-.64M	$-8.68M
Cost of Revenue
Net Cash Flow	$-.76M	$3.79M	$-.76M
PE Ratio